Marketing-Börse PLUS - Fachbeiträge zu Marketing und Digitalisierung
print logo

Corneal Neovascularization - Pipeline Review, H1 2016

ResearchMoz added Latest Research Report titled " Corneal Neovascularization - Pipeline Review, H1 2016 " to it's Large Report database.
Sagar Jagtap | 07.06.2016

Summary

Global Markets Directs, Corneal Neovascularization - Pipeline Review, H1 2016, provides an overview of the Corneal Neovascularization pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Corneal Neovascularization, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Corneal Neovascularization and features dormant and discontinued projects.

Download free Sample PDF report with TOC: http://www.researchmoz.us/enquiry.php?type=S&repid=726779

Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Directs proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Click to submit Query/ Enquiry: http://www.researchmoz.us/enquiry.php?type=E&repid=726779

Table of Contents

Table of Contents 2
List of Tables 4
List of Figures 4
Introduction 5
Global Markets Direct Report Coverage 5
Corneal Neovascularization Overview 6
Therapeutics Development 7
Pipeline Products for Corneal Neovascularization - Overview 7
Pipeline Products for Corneal Neovascularization - Comparative Analysis 8
Corneal Neovascularization - Therapeutics under Development by Companies 9
Corneal Neovascularization - Therapeutics under Investigation by Universities/Institutes 10
Corneal Neovascularization - Pipeline Products Glance 11
Late Stage Products 11
Early Stage Products 12
Corneal Neovascularization - Products under Development by Companies 13
Corneal Neovascularization - Products under Investigation by Universities/Institutes 14
Corneal Neovascularization - Companies Involved in Therapeutics Development 15
Amakem NV 15
Gene Signal International SA 16
Sirnaomics, Inc. 17
Corneal Neovascularization - Therapeutics Assessment 18
Assessment by Monotherapy Products 18
Assessment by Target 19

About ResearchMoz

ResearchMoz is the world’s fastest growing collection of market research reports worldwide. Our database is composed of current market studies from over 100 featured publishers worldwide. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives. ResearchMoz’s service portfolio also includes value-added services such as market research customization, competitive landscaping, and in-depth surveys, delivered by a team of experienced Research Coordinators.

Contact Us:

Mr. Nachiket
Albany NY - 12207
United States
Tel: +1-518-621-2074
Tel: 866-997-4948 (Us-Canada Toll Free)
Email: sales@researchmoz.us
Follow us on LinkedIn at: http://bit.ly/1TBmnVG

About the tenderer: Sagar Jagtap